Table 1.
No. | Process | Drug con. (w/v) | Flow rate (mL/h) | Morphology c | Total drug content d | Diameter (nm) | ||
---|---|---|---|---|---|---|---|---|
|
|
|||||||
Shell a | Core b | Shell | Core | |||||
F1 | Single | - | 3% | - | 1.0 | Linear | 11.11% | 570 ± 140 |
F2 | 5% | - | 1.0 | - | - | - | - | |
| ||||||||
F3 | Coaxial | 5% | 3% | 0.3 | 1.0 | Linear | 13.64% | 930 ± 170 |
F4 | 5% | 6% | 0.3 | 1.0 | Linear | 20.83% | 910 ± 220 | |
F5 | 5% | 6% | 0.3 | 0.5 | Mixed | - | - |
Shell fluid consists of 15% (w/v) PVP K25 and a fixed APAP concentration of 5% (w/v) in a mixture of ethanol and DMAc (8:2, v:v);
Core fluid consists of 24% (w/v) EC and a varied concentration of APAP in ethanol;
“Linear” morphology refers to nanofibers with few beads or spindles and “Mixed” morphology to nanofibers exhibiting beads-on-a-string or spindles-on-a-string features;
The theoretical value (w/w) in the solid nanofibers calculated according to the shell and core fluid flow rates and the drug content in the shell and core solutions.